Literature DB >> 32938718

Biosynthesis of GlcNAc-rich N- and O-glycans in the Golgi apparatus does not require the nucleotide sugar transporter SLC35A3.

Bozena Szulc1, Paulina Sosicka1,2, Dorota Maszczak-Seneczko1, Edyta Skurska1, Auhen Shauchuk1, Teresa Olczak1, Hudson H Freeze2, Mariusz Olczak3.   

Abstract

Nucleotide sugar transporters, encoded by the SLC35 gene family, deliver nucleotide sugars throughout the cell for various glycosyltransferase-catalyzed glycosylation reactions. GlcNAc, in the form of UDP-GlcNAc, and galactose, as UDP-Gal, are delivered into the Golgi apparatus by SLC35A3 and SLC35A2 transporters, respectively. However, although the UDP-Gal transporting activity of SLC35A2 has been clearly demonstrated, UDP-GlcNAc delivery by SLC35A3 is not fully understood. Therefore, we analyzed a panel of CHO, HEK293T, and HepG2 cell lines including WT cells, SLC35A2 knockouts, SLC35A3 knockouts, and double-knockout cells. Cells lacking SLC35A2 displayed significant changes in N- and O-glycan synthesis. However, in SLC35A3-knockout CHO cells, only limited changes were observed; GlcNAc was still incorporated into N-glycans, but complex type N-glycan branching was impaired, although UDP-GlcNAc transport into Golgi vesicles was not decreased. In SLC35A3-knockout HEK293T cells, UDP-GlcNAc transport was significantly decreased but not completely abolished. However, N-glycan branching was not impaired in these cells. In CHO and HEK293T cells, the effect of SLC35A3 deficiency on N-glycan branching was potentiated in the absence of SLC35A2. Moreover, in SLC35A3-knockout HEK293T and HepG2 cells, GlcNAc was still incorporated into O-glycans. However, in the case of HepG2 cells, no qualitative changes in N-glycans between WT and SLC35A3 knockout cells nor between SLC35A2 knockout and double-knockout cells were observed. These findings suggest that SLC35A3 may not be the primary UDP-GlcNAc transporter and/or different mechanisms of UDP-GlcNAc transport into the Golgi apparatus may exist.
© 2020 Szulc et al.

Entities:  

Keywords:  CRISPR/Cas; Golgi; Golgi apparatus; N-glycan; O-glycan; UDP–N-acetylglucosamine; glycobiology; glycoconjugate; glycoprotein biosynthesis; glycosylation; membrane transport; nucleotide sugar transporter; post-translational modification (PTM); transporter

Year:  2020        PMID: 32938718      PMCID: PMC7705316          DOI: 10.1074/jbc.RA119.012362

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  A human case of SLC35A3-related skeletal dysplasia.

Authors:  Andrew C Edmondson; Emma C Bedoukian; Matthew A Deardorff; Donna M McDonald-McGinn; Xueli Li; Miao He; Elaine H Zackai
Journal:  Am J Med Genet A       Date:  2017-08-04       Impact factor: 2.802

2.  Nucleotide sugar transporters of the Golgi apparatus: from basic science to diseases.

Authors:  Carolina E Caffaro; Carlos B Hirschberg
Journal:  Acc Chem Res       Date:  2006-11       Impact factor: 22.384

3.  Identification and characterization of human Golgi nucleotide sugar transporter SLC35D2, a novel member of the SLC35 nucleotide sugar transporter family.

Authors:  Nobuhiro Ishida; Toshiyasu Kuba; Kazuhisa Aoki; Shoichiro Miyatake; Masao Kawakita; Yutaka Sanai
Journal:  Genomics       Date:  2005-01       Impact factor: 5.736

4.  Molecular characterization of human UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter, a novel nucleotide sugar transporter with dual substrate specificity.

Authors:  M Muraoka; M Kawakita; N Ishida
Journal:  FEBS Lett       Date:  2001-04-20       Impact factor: 4.124

5.  In Situ Proximity Ligation Assay (PLA) Analysis of Protein Complexes Formed Between Golgi-Resident, Glycosylation-Related Transporters and Transferases in Adherent Mammalian Cell Cultures.

Authors:  Dorota Maszczak-Seneczko; Paulina Sosicka; Teresa Olczak; Mariusz Olczak
Journal:  Methods Mol Biol       Date:  2016

6.  Overexpression of UDP-GlcNAc transporter partially corrects galactosylation defect caused by UDP-Gal transporter mutation.

Authors:  Dorota Maszczak-Seneczko; Teresa Olczak; Piotr Jakimowicz; Mariusz Olczak
Journal:  FEBS Lett       Date:  2011-09-01       Impact factor: 4.124

7.  A missense mutation in the bovine SLC35A3 gene, encoding a UDP-N-acetylglucosamine transporter, causes complex vertebral malformation.

Authors:  Bo Thomsen; Per Horn; Frank Panitz; Emøke Bendixen; Anette H Petersen; Lars-Erik Holm; Vivi H Nielsen; Jørgen S Agerholm; Jens Arnbjerg; Christian Bendixen
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

8.  UDP-galactose (SLC35A2) and UDP-N-acetylglucosamine (SLC35A3) Transporters Form Glycosylation-related Complexes with Mannoside Acetylglucosaminyltransferases (Mgats).

Authors:  Dorota Maszczak-Seneczko; Paulina Sosicka; Beata Kaczmarek; Michał Majkowski; Marcin Luzarowski; Teresa Olczak; Mariusz Olczak
Journal:  J Biol Chem       Date:  2015-05-05       Impact factor: 5.157

9.  Complementarity of electrophoretic, mass spectrometric, and gene sequencing techniques for the diagnosis and characterization of congenital disorders of glycosylation.

Authors:  Arnaud Bruneel; Sophie Cholet; Valérie Drouin-Garraud; Marie-Line Jacquemont; Aline Cano; André Mégarbané; Coralie Ruel; David Cheillan; Thierry Dupré; Sandrine Vuillaumier-Barrot; Nathalie Seta; François Fenaille
Journal:  Electrophoresis       Date:  2018-07-03       Impact factor: 3.535

10.  Comparative analysis of involvement of UGT1 and UGT2 splice variants of UDP-galactose transporter in glycosylation of macromolecules in MDCK and CHO cell lines.

Authors:  Dorota Maszczak-Seneczko; Teresa Olczak; Livius Wunderlich; Mariusz Olczak
Journal:  Glycoconj J       Date:  2011-09-06       Impact factor: 2.916

View more
  4 in total

1.  Novel Insights into Selected Disease-Causing Mutations within the SLC35A1 Gene Encoding the CMP-Sialic Acid Transporter.

Authors:  Bożena Szulc; Yelyzaveta Zadorozhna; Mariusz Olczak; Wojciech Wiertelak; Dorota Maszczak-Seneczko
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

2.  The Solute Carrier MFSD1 Decreases the Activation Status of β1 Integrin and Thus Tumor Metastasis.

Authors:  Marko Roblek; Julia Bicher; Merel van Gogh; Attila György; Rita Seeböck; Bozena Szulc; Markus Damme; Mariusz Olczak; Lubor Borsig; Daria E Siekhaus
Journal:  Front Oncol       Date:  2022-02-08       Impact factor: 6.244

3.  SLC35A2 Deficiency Promotes an Epithelial-to-Mesenchymal Transition-like Phenotype in Madin-Darby Canine Kidney Cells.

Authors:  Magdalena Kot; Ewa Mazurkiewicz; Maciej Wiktor; Wojciech Wiertelak; Antonina Joanna Mazur; Andrei Rahalevich; Mariusz Olczak; Dorota Maszczak-Seneczko
Journal:  Cells       Date:  2022-07-23       Impact factor: 7.666

Review 4.  Delivery of Nucleotide Sugars to the Mammalian Golgi: A Very Well (un)Explained Story.

Authors:  Dorota Maszczak-Seneczko; Maciej Wiktor; Edyta Skurska; Wojciech Wiertelak; Mariusz Olczak
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.